DAVID ALLISON to Hypoglycemic Agents
This is a "connection" page, showing publications DAVID ALLISON has written about Hypoglycemic Agents.
Connection Strength
0.872
-
Neglecting regression to the mean continues to lead to unwarranted conclusions: Letter regarding "The magnitude of weight loss induced by metformin is independently associated with BMI at baseline in newly diagnosed type 2 diabetes: Post-hoc analysis from data of a phase IV open-labeled trial". Adv Clin Exp Med. 2019 Nov; 28(11):1569-1570.
Score: 0.463
-
Metformin supplementation and life span in Fischer-344 rats. J Gerontol A Biol Sci Med Sci. 2010 May; 65(5):468-74.
Score: 0.238
-
Unaccounted for regression to the mean renders conclusion of article titled "Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor tofogliflozin" unsubstantiated. Diabetes Obes Metab. 2018 08; 20(8):2039-2040.
Score: 0.104
-
Calorie restriction: what recent results suggest for the future of ageing research. Eur J Clin Invest. 2010 May; 40(5):440-50.
Score: 0.060
-
Prescription medications: a modifiable contributor to obesity. South Med J. 1999 Sep; 92(9):898-904.
Score: 0.007